Accueil>>Natural Products>>Tigloylgomisin H

Tigloylgomisin H

Catalog No.GC37791

La tigloylgomisine H est un lignane isolé des fruits de S. chinensis, peut induire une activité de quinone réductase (QR) dans les cellules d'hépatocarcinome de souris Hepa1c1c7. La tigloylgomisine H fonctionne comme un inducteur monofonctionnel qui régule spécifiquement À la hausse l'enzyme de détoxification de phase II NQO1 via la voie NF-E2-related factor 2 (Nrf2)-ARE, représente ainsi un agent potentiel de prévention du cancer du foie.

Products are for research use only. Not for human use. We do not sell to patients.

Tigloylgomisin H Chemical Structure

Cas No.: 66069-55-4

Taille Prix Stock Qté
1mg Please Inquire Please Inquire
5mg Please Inquire Please Inquire

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tigloylgomisin H is a lignan isolated from the fruits of S. chinensis, can induce quinone reductase (QR) activity in Hepa1c1c7 mouse hepatocarcinoma cells. Tigloylgomisin H functions as a monofunctional inducer that specifically upregulates phase II detoxification enzyme NQO1 through the NF-E2-related factor 2 (Nrf2)-ARE pathway, thus represents a potential liver cancer prevention agent[1].

[1]. Lee SB, et al. Induction of the phase II detoxification enzyme NQO1 in hepatocarcinoma cells by lignans from the fruit of Schisandra chinensis through nuclear accumulation of Nrf2. Planta Med. 2009 Oct;75(12):1314-8.

Avis

Review for Tigloylgomisin H

Average Rating: 5 ★★★★★ (Based on Reviews and 2 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tigloylgomisin H

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.